Related Experiment Videos
[When in pregnancy should screening for Chlamydia be carried out?]
H Schlögl1, R Rudelstorfer, K Kosian
1II. Universitäts-Frauenklinik Wien.
Zeitschrift Fur Geburtshilfe Und Perinatologie
|November 1, 1988
Summary
Screening pregnant women for Chlamydia trachomatis between 34-38 weeks is recommended. Early diagnosis and erythromycin treatment can prevent neonatal infection, as history and vaginal smears are unreliable indicators.
Area of Science:
- Obstetrics and Gynecology
- Infectious Diseases
- Neonatal Health
Context:
- Prenatal care aims to diagnose cervical infections like Chlamydia trachomatis.
- Preventing neonatal transmission is a critical aspect of prenatal care.
- The study investigates optimal screening timing and risk factors for Chlamydia trachomatis in pregnancy.
Purpose:
- To determine the most meaningful gestational age for Chlamydia trachomatis screening in pregnant women.
- To assess if medical history, vaginal smears, or cervical cerclage indicate Chlamydia trachomatis infection risk.
- To evaluate the spontaneous remission rate and neonatal transmission of Chlamydia trachomatis.
Summary:
- Chlamydia trachomatis screening in pregnant women is crucial for preventing neonatal infections.
- 11% of pregnant women tested positive at booking; over half experienced spontaneous remission.
- Newborns of infected mothers (at follow-up) tested positive, highlighting transmission risk.
- No correlation was found between medical history, vaginal smears, or cervical cerclage and infection incidence.
Impact:
- Recommends screening all pregnant women between 34-38 weeks gestation.
- Proposes erythromycin treatment (4 x 500 mg t.i.d.) for infected individuals.
- Highlights the importance of timely screening and treatment to improve neonatal outcomes.